Strides Pharma Science announced that its step down subsidiary Strides Pharma Global (SPG) has acquired a majority stake in Fairmed Healthcare AG(Fairmed), a Switzerland based company with a portfolio of high]quality generic products encompassing prescription and over]the]counter drugs across several therapeutic segments.
Under the terms of the agreement, SPG will hold 70% of the issued capital of Fairmed.
Strides has infused CHF 2.2 Million into the entity in lieu of the equity stake.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)